EUVIMEDEUVIMED entdecken
Crossref

Gastrointestinal and hepatobiliary manifestations of COVID-19 infection: A single center study from Pakistan

Sami Ullah Mumtaz, Rabiah Haque, Tayyeba Komal, Somia Iqtadar, zafar Niaz, Sajid Abaidullah Abaidullah

Pakistan journal of Gastroenterology · 2025

DOI: 10.63521/pjg.41.3.2025.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pakistan journal of Gastroenterology, 2025. Verfasst von Sami Ullah Mumtaz und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Coronavirus disease was a global challenge affecting around 229 countries with over 700 million confirmed cases with significant morbidity and mortality. OBJECTIVE: To determine the frequency of hepatobiliary manifestations in patients of COVID-19. METHODOLOGY: This was a cross-sectional study conducted at North Medical Ward, Mayo Hospital, Lahore for three months. After ethical approval of the study, 200 COVID-19 RT-PCR positive cases of ages 15 to 80 years were included in the study. Complete history & examination regarding hepatobiliary symptoms were noted. Liver function tests & prothrombin time were sent to pathology laboratory & results were noted. Data was analyzed using SPSS-26. Quantitative variables like age, bilirubin, Aminotransferases & Prothrombin time were taken as mean ± standard deviation. Qualitative variables like gender, hepatobiliary symptoms were taken as frequency and percentages. RESULTS: The most common symptom at presentation was diarrhea 30 (15.0%) followed by fatigue, pruritic and anorexia 17 (8.5%), nausea, vomiting and abdominal pain 15 (7.5%), body petechiae & purpura in 13(6.5%), Right hypochondrial pain 11(5.5%) & Hiccup and dark color urine 1(0.5%). On laboratory findings,17(8.5%) patients had elevated bilirubin levels while AST was raised in 79(39.5%) of cases, ALT in 23(11.5%), Alkaline phosphatase in 6(3.0%), GGT in 95(47.5%) of cases. 8 (4.0%) cases showed decrease albumin level and 12(6.0%) cases had prolonged PT levels. CONCLUSION: Hepatobiliary symptoms and laboratory derangements are not uncommon in patients with COVID-19. So, attention should be given to these extra-pulmonary symptoms to avoid any delay in treatment & disease progression and complications.

Zitieren

APA

Mumtaz, S. U., Haque, R., Komal, T., Iqtadar, S., Niaz, Z., & Abaidullah, S. A. (2025). Gastrointestinal and hepatobiliary manifestations of COVID-19 infection: A single center study from Pakistan. Pakistan journal of Gastroenterology. https://doi.org/10.63521/pjg.41.3.2025.10

Vancouver

Mumtaz SU, Haque R, Komal T, Iqtadar S, Niaz Z, Abaidullah SA. Gastrointestinal and hepatobiliary manifestations of COVID-19 infection: A single center study from Pakistan. Pakistan journal of Gastroenterology. 2025. doi:10.63521/pjg.41.3.2025.10

BibTeX
@article{Mumtaz2025,
  author = {Mumtaz, Sami Ullah and Haque, Rabiah and Komal, Tayyeba and Iqtadar, Somia and Niaz, zafar and Abaidullah, Sajid Abaidullah},
  title = {Gastrointestinal and hepatobiliary manifestations of COVID-19 infection: A single center study from Pakistan},
  journal = {Pakistan journal of Gastroenterology},
  year = {2025},
  doi = {10.63521/pjg.41.3.2025.10}
}
Kostenlos starten →